Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03936101 · ClinicalTrials.gov registry record
Prenatal Genetic Diagnosis by Genomic Sequencing
A clinical trial, sponsored by Columbia University.
- Completed
- Registry status
- 1,097
- Enrollment target
NCT03936101 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 1,097 participants.
The verdict
NCT03936101 has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 1,097 participants
- Enrollment target
Study Summary
This study is evaluating the impact of prenatal sequencing on the management of fetuses with ultrasound abnormalities. The hypothesis is that a significant subset of fetal abnormalities have a genetic cause that can be identified by sequencing and that prenatal knowledge of this information will improve prenatal care, reduce unnecessary diagnostic testing, reduce the cost of care, and improve the quality of life for both the child and the family.
Interventions
- DIAGNOSTIC_TEST Prenatal Genomic Sequencing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,097 participants |
| Start Date | 2019-06-28 |
| Est. Completion | 2024-03-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03936101
The ClinicalTrials.gov registry entry for NCT03936101 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,097 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Prenatal Genomic Sequencing is the first listed.
NCT03936101 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03936101 about?
NCT03936101 is a clinical study titled "Prenatal Genetic Diagnosis by Genomic Sequencing". This study is evaluating the impact of prenatal sequencing on the management of fetuses with ultrasound abnormalities. The hypothesis is that a significant subset of fetal abnormalities have a genetic cause that can be identified by sequencing and that prenatal knowledge of this information will imp...
What is the current status of trial NCT03936101?
This trial is currently completed. The enrollment target is 1,097 participants. The study started on 2019-06-28. Estimated completion is 2024-03-25.
What interventions are being tested in trial NCT03936101?
The interventions under investigation include: Prenatal Genomic Sequencing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03936101?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.